Biogen Inc. shares slipped in the extended session Monday following a report that the biotech company is set to appoint a new chief executive. Biogen shares declined 1.2% to $275.50 after hours. Biogen is planning on announcing Chief Commercial Officer Michel Vounatsos as its new CEO to succeed George Scangos as early as this week, according to Reuters, citing people close to the matter.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News